2024-07-08T11:03:13-07:00 2023-12-31 680260103 REGALIA & ASSOCIATES CPAS 103 TOWN COUNTRY DR STE K DANVILLE CA 94526 990 2023-01-01 272444495 The Bluefield Project to Cure Frontotemporal Dementia BLUE 4156261501 637 Carolina Street San Francisco CA 94107 Laura Mitic President 4156261501 2024-07-08 true Laura Mitic 999009999 true Douglas W Regalia P00186389 9253140390 2 AAL1 IAL1 FAL1 2023 2023-04-26 12:10:37Z Robin Richards Donohoe 637 Carolina Street San Francisco CA 94107 2086433 false X www.bluefieldproject.org X 2010 CA The Organization's primary mission is to help find a cure for Frontotemporal dementia (FTD). The Bluefield Project was founded by a family group whose lives have been directly impacted by FTD. FTD is a clinical syndrome caused by degeneration of the [continued on page 2] 8 5 3 5 0 1445266 444020 522 28051 1413677 1614362 0 2859465 2086433 4272328 5267997 0 865654 849316 0 5883 2248984 2962758 7386966 9080071 -4527501 -6993638 29690825 25667529 355873 2207386 29334952 23460143 frontal lobe of the brain and may extend back to the temporal lobe. FTD is the second most common early-onset dementia after Alzheimer's disease. false false 8784474 5267997 28501 The Bluefield Project is an effort to find a treatment or cure for frontotemporal dementia (FTD) by funding FTD-related research. By privately funding basic, translational and clinical FTD-related research, the donor group that established The Bluefield Project has significantly increased the number of labs studying FTD. The Consortium for Frontotemporal Dementia Research, funded in part by The Bluefield Project, applies a business model to research by incentivizing the sharing of data and reagents, thereby accelerating discovery. FTD encompasses a group of complex neurodegenerative diseases characterized by progressive deterioration of the frontotemporal lobes and resultant loss of decision-making abilities and control of behavior, emotion, and language. 8784474 true true false false false false false false false false false true false false true true true false false true true true false false false false false true true true false false false false false false false false false false false false false false false false false true 11 0 true 3 true false false false false false false false 0 false false false false false false false X 8 5 true false false false false false false true true false false true true true true true true true true false CA X X X Laura Mitic 4156261501 637 Carolina Street San Francisco CA 94107 X Rodney Perlman President 40.00 0.00 343000 0 77118 Bruce Miller MD Director 1.00 0.00 X 410000 0 0 Robert V Farese Jr MD Director 1.00 0.00 X 367193 0 0 Laura Mitic President 20.00 20.00 X 101728 136319 0 Alexandra Nicholson Assoc Dir Rsrch 40.00 0.00 128000 0 13011 Ian Massey PhD Director 1.00 0.00 X 10000 0 0 Robin Richards Donohoe Board Chair 2.00 0.00 X X 0 0 0 Christopher Donohoe Secty/Treasurer 0.50 0.00 X X 0 0 0 Roy Richards Jr Director 0.50 0.00 X 0 0 0 Williamson Bradford MD Director 0.50 0.00 X 0 0 0 Karen Chen PhD Director 1.00 0.00 X 0 0 0 1359921 136319 90129 5 true true true Adaptive RC LLC 3909 Park Blvd Palo Alto CA 94306 Consulting 186849 Anne Alward 650 Delancey Street Apt 407 San Francisco CA 94107 Consulting 182568 2 444020 444020 Program fees 624100 28051 28051 28051 1614362 1614362 0 0 0 0 0 0 0 0 2086433 28051 1614362 3586808 3586808 10813 10813 1670376 1670376 0 444728 392918 51217 593 0 277200 244906 31924 370 0 94684 79870 10904 3910 32704 28742 3766 196 0 0 58554 58554 0 0 74511 74511 91201 89124 1807 270 0 33359 20274 12842 243 4562 4562 0 34364 30525 3605 234 47561 32577 14984 0 0 0 0 0 7190 6085 1038 67 Neurofilament surveillance 1661451 1661451 Registry AFTD amd FTD 930005 930005 Grant termination 20000 20000 0 9080071 8784474 289714 5883 557417 9996 1291342 221881 805097 135922 0 0 0 0 0 24572 219935 0 0 26760888 24861786 0 0 251509 218009 29690825 25667529 255313 1845641 100560 361745 355873 2207386 X 28764088 23460143 570864 29334952 23460143 29690825 25667529 X -6993638 1103504 15325 X X false true X true false X 2359563 375507 1500802 1445266 444020 6125158 0 0 2359563 375507 1500802 1445266 444020 6125158 1091490 5033668 974192 801290 2900577 1413677 1614362 7704098 0 0 13829256 31180 0.36400 0.36550 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 24861786 Grants payable 293922 Operating lease payable 67823 361745 X 3376290 1103504 550864 1654368 1721922 74511 290000 364511 2086433 9005560 9005560 74511 74511 9080071 Part X : FIN48 Footnote Income TaxesFinancial statement presentation follows the recommendations of ASC 740, Income Taxes. Under ASC 740, Bluefield is required to report information regarding its exposure to various tax positions taken by the organization and requires a two-step process that separates recognition from measurement. The first step is determining whether a tax position has met the recognition threshold; the second step is measuring a tax position that meets the recognition threshold. Management believes that Bluefield has adequately evaluated its current tax positions and has concluded that as of December 31, 2023, Bluefield does not have any uncertain tax positions for which a reserve or an accrual for a tax liability would be necessary.Bluefield has received notification from the Internal Revenue Service and the State of California that it qualifies for tax-exempt status under Section 501(c)(3) of the Internal Revenue Code and Section 23701d of the California Revenue and Taxation Code. This exemption is subject to periodic review by the federal and state taxing authorities and management is confident that the organization continues to satisfy all federal and state statutes in order to qualify for continued tax exemption status. Bluefield may periodically receive unrelated business income requiring the organization to file separate tax returns under federal and state statutes. Under such conditions, Bluefield calculates and accrues the applicable taxes payable. Part XI, Line 2d: Other revenue amounts included in F/S but not included on form 990 Net assets released from restrictions $550864 Part XI, Line 4b: Other revenue amounts included on 990 but not included in F/S Temp Restricted Contributions $290000 true United Kingdom 0 1 Funding Medical Research Clinical Medicine Grants 0 The Netherlands 0 1 Funding Medical Research Clinical Medicine Grants 0 Denmark 0 1 Funding Medical Research Clinical Medicine Grants 0 Sweden 0 1 Funding Medical Research Clinical Medicine Grants 0 4 4 Denmark Medical Research 252745 Wire Actual Cost Netherlands Medical Research 195309 Wire Actual Cost Sweden Medical Research 179300 Wire Actual Cost United Kingdom Medical Research 106673 Wire Actual Cost United Kingdom Medical Research 155256 Wire Actual Cost United Kingdom Medical Research 156394 Wire Actual Cost United Kingdom Medical Research 624699 Wire Actual Cost 1 6 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US A budget is prepared in advance of all international work. The Board approves the total grant amount and then funding is then authorized and executed. Discussions, e-mails, and other techniques of communication are employed to ensure that funds are utilized according to the original intent. Accomplishments are documented in writing and retained by the organization's main office. Part II, Line 1 - Method of Accounting Accrual method of accounting is utilized true Harvard University Oxford Street Cambridge MA 02138 530199180 269500 0 Research Mayo Clinic Rochester 200 1st Street SW Rochester MN 55905 416011702 293922 0 Research Memorial Sloan Kettering Canc 1275 York Avenue New York NY 10065 131624082 442193 0 Research University of Alabama 801 Campus Drive Tuscaloosa AL 35487 636001138 180000 0 Research University of California 220 MONTGOMERY ST FL 5 SAN FRANCISCO CA 94104 942829914 2394193 0 Research 5 0 Research Support 2 10813 X X X X false false false false false false false false false Bruce Miller MD Director 10000 400000 410000 Ian Massey PhD Director 10000 10000 Laura Mitic President 101728 136319 101728 136319 Robert V Farese Jr MD Director 367193 367193 Rodney Perlman President 343000 42000 35118 420118 Dr Bruce Miller Board Member 10000 Consultation false Ian Massey Board Member 10000 Consultation false Schedule L, Part V Supplemental Information Related Party TransactionsDuring the year ended December 31, 2023:Related Party TransactionsDuring the year ended December 31, 2023:[1] Board Member Bruce Miller, MD received $10,000 from Bluefield Project as compensation for certain consultation services.[2] Board Member Bruce Miller, MD (through his association with University of California - San Francisco) received grant funding totaling $400,000 from Bluefield Project for research work performed.[3] Board member Ian Massey received a $10,000 from Bluefield Project as compensation for certain consultation services.[4] Board Member Robert Farese, MD (through his association with Memorial Sloan Kettering Cancer Center) received grant funding totaling $367,193 from Bluefield Project for research work performed. Form 990, Part VI, Section A, Line 2 Roy Richards, Jr., Robin Richards Donohoe, and Nancy Richards Farese are siblings. Robin Richards Donohoe is married to Christopher Donohoe. Nancy Richards Farese is married to Robert V. Farese, Jr. Form 990, Part VI, Section B, Line 11b Form 990 is prepared by an outside tax professional. The form is then reviewed by the organization's management. After a full review, the final version of the tax return is provided to all members of the organization's voting body. A representative of management authorizes the final form 990 which is then e-filed with the internal revenue service. Form 990, Part VI, Section B, Line 12c Members of the Board of Directors review all potential conflicts of interest periodically. Top management and all Board members are required to disclose potential conflicts and any related party affiliations. The organization seeks full transparency on all relationships. Any potential conflicts (in fact or appearance) are discussed openly and resolved in accordance with the organization's policies and procedures. Form 990, Part VI, Section B, Line 15a Members of the board of directors review the compensation of all high-level personnel periodically in accordance with IRS rules and regulations. Efforts are made to secure compensation data from industry sources in order to determine competitiveness and appropriateness of salaries. Every effort is made to ensure that the process is thorough and transparent in accordance with IRS guidelines and the organization's policies and procedures. Form 990, Part VI, Section B, Line 15b Members of the board of directors receive compensation for certain services rendered. This compensation is reviewed and approved by the entire Board. Form 990, Part VI, Section C, Line 18 Tax returns are available for download from several websites and by request from the organization's office in Berkeley, California. Form 990, Part VI, Section C, Line 19 All of the organization's governing documents, financial statements, and other legal filings are maintained in a secure environment and held available for inspection by tax authorities and the general public. Tax returns are posted annually to our website and to www.guidestar.org (where they are available for viewing as electronic copies) and are also available by request from the organization's office. Form 990, Part XI, Line 9 Change in discount related to long-term receivables = $15325 Form 990, Part XII, Line 2c Under the California Nonprofit Integrity Act, an exempt organization with annual revenue of $2 million or more is required to have an Audit Committee to select an audit Firm, review the audit, and approve the audit of its annual financial statements.